A Paris-based company founded by Professor Francine Behar-Cohen has announced the closure of a EUR1.6 million funding round led by French investors InnoBio Fund and Inserm Transfert Initiative. The company has recruited a number of scientists and will focus on the development of an electroporation device for ocular drug delivery.